Venetoclax with decitabine as frontline treatment in younger adults with newly diagnosed ELN adverse-risk AML.
Xie J, Bao X, Xue SL, Shen H, Cen J, Yao L, Pan J, Zhu M, Liu D, Hu X, Wu Q, Zhang J, Dai H, Cao Y, He X, Tang X, Sun AN, Wang Y, Fu J, Qiu H, Yang X, Chen S, Wu D.
Xie J, et al. Among authors: wu d, wu q.
Blood. 2023 Oct 12;142(15):1323-1327. doi: 10.1182/blood.2023020102.
Blood. 2023.
PMID: 37478399
Free article.
No abstract available.